This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Prescribing Benzodiazepines for Patients With Substance Use Disorders

Daniel Z. Lieberman, MD

Published: November 1, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: A review of physician prescribing practices for Medicaid beneficiaries in New Hampshire by Clark and colleagues1 uncovered a disturbing trend showing that patients with cooccurring substance use disorders (SUDs) received larger doses of benzodiazepines and had higher rates of benzodiazepine use than those without SUDs. They noted that the American Psychiatric Association (APA) guidelines2 recommend caution when prescribing benzodiazepines to persons with SUDs, and the authors rightly recommended that prescribing physicians reassess their use of these medications.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: Addiction , Substance Use Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Clinical and Practical Psychopharmacology

Antipsychotic Augmentation With N-Acetylcysteine for Patients With Schizophrenia

Dr Andrade discusses whether or not recent findings support the use of NAC as antipsychotic augmentation in...